DALLAS–(BUSINESS WIRE)–Verily today announced a $300 million investment round led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz and other investors, to advance the next phase of its precision health AI strategy. With this funding round, Alphabet will be a significant minority investor in Verily, while no longer having a controlling stake. “Today is an important step in our mission to bring the promise of precision health to everyone,” sai
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
